ArticleFrontiers in immunology2020

Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin

Christian Binder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.